Mathavan, S., Mikov, M., Golocorbin-Kon, S., & Al-Salami, H. (2017). Diabetes development increased concentrations of the conjugated bile acid, taurocholic acid in serum, while treatment with microencapsulated-taurocholic acid exerted no hypoglycaemic effects. Elsevier Science.
Chicago Style (17th ed.) CitationMathavan, S., M. Mikov, S. Golocorbin-Kon, and Hani Al-Salami. Diabetes Development Increased Concentrations of the Conjugated Bile Acid, Taurocholic Acid in Serum, While Treatment with Microencapsulated-taurocholic Acid Exerted No Hypoglycaemic Effects. Elsevier Science, 2017.
MLA (9th ed.) CitationMathavan, S., et al. Diabetes Development Increased Concentrations of the Conjugated Bile Acid, Taurocholic Acid in Serum, While Treatment with Microencapsulated-taurocholic Acid Exerted No Hypoglycaemic Effects. Elsevier Science, 2017.